INEO Announces Fiscal Fourth Quarter and Annual 2025 Financial Results 
Imagen Network Adopts Gemini Models to Power Adaptive Community Engagement 
LUNA Financial Education Initiative Launches Research Highlighting Growing Female Participation in Investing 
Hillcrest Announces Closing of First Tranche of Unit Offering 
Fab-Form Industries Ltd. Announces Results for the Year Ended 30 June 2025 Day One Reports Second Quarter 2021 Financial Results and Corporate Progress
DAY101 Granted Rare Pediatric Disease Designation from FDA DAY101 Granted Orphan Designation from European Commission…
Akoya Reports 53% Revenue Growth in the Second Quarter of 2021
MARLBOROUGH, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2022
U.S. FDA reviewing premarket approval (PMA) submission for LungFit® PH to treat persistent pulmonary hypertension…
Clearside Biomedical Announces Second Quarter 2021 Financial Results and Provides Corporate Update
– Enrollment Underway in Cohort 2 of OASIS Wet AMD Phase 1/2a Trial with Data Expected…
Talis Biomedical Announces Second Quarter 2021 Financial Results and Business Progress
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific MENLO PARK, Calif., Aug. 10, 2021…
Zosano Pharma Reports Second Quarter 2021 Financial Results
FREMONT, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company,…
Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance
DURHAM, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the…
CohBar Reports Second Quarter 2021 Financial Results and Provides Business Update
Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., Aug….
Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
– Commenced dosing in Phase 3 PATHFNDR-1 study – – Phase 1 single-ascending dose data…
CohBar Announces Positive Topline Results from the Phase 1a/1b Study of CB4211 Under Development for NASH and Obesity
CB4211 was well-tolerated and appeared safe with no serious adverse events Robust reductions in ALT…
Altimmune Announces Second Quarter 2021 Financial Results and Provides a Corporate Update
12-week Data Readout from ALT-801 Phase 1 Clinical Trial Expected in September Approximately $218…
POINT Biopharma Announces Early Completion of enrollment and initial dosing in the Lead-In of its Phase 3 SPLASH study of PNT2002 for mCRPC
INDIANAPOLIS, Aug. 10, 2021 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (NASDAQ: PNT), a company…
Applied Molecular Transport Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Top-line data readouts expected from four Phase 2 trials of oral AMT-101, consistent with previous…
Crinetics Pharmaceuticals’ Oral ACTH Antagonist, CRN04894, Demonstrates Pharmacologic Proof-of-Concept with Dose-Dependent Cortisol Suppression in Single Ascending Dose Portion of Phase 1 Study
CRN04894 Phase 1 Study Progressing to Multiple Ascending Dose Cohorts Management Hosting Webcast and Conference…
aTyr Pharma Announces Second Quarter 2021 Results and Provides Corporate Update
Data from Phase 1b/2a clinical trial of ATYR1923 in pulmonary sarcoidosis expected in mid-September 2021….
Letter to Shareholders from the Chairman of the Board Ilya Shpurov
Nicosia, Cyprus, Aug. 10, 2021 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC: (RAFA) shares the…
Cosmos Holdings to Open Flagship Store on Alibaba’s Tmall Global, World’s Largest Cross-Border E-Commerce Marketplace with 500M Monthly Active Users
Company Partners with Leading China E-Commerce Solutions Provider REMAI to Launch Sky Premium Life Products…
INmune Bio, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference
BOCA RATON, Florida, Aug. 10, 2021 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”),…
Medexus Schedules First Quarter Fiscal 2022 Conference Call
TORONTO and CHICAGO, Aug. 10, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or…
Longeveron to Release Second Quarter 2021 Financial Results and Hold Conference Call on August 13, 2021
MIAMI, Aug. 10, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…